Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
53,370,851
-
Shares change
-
+3,399,448
-
Total reported value, excl. options
-
$762,477,663
-
Value change
-
+$42,467,188
-
Put/Call ratio
-
90.31%
-
Number of buys
-
84
-
Number of sells
-
-59
-
Price
-
$14.24
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q3 2021
167 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2021.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53,370,851 shares
of 126,273,814 outstanding shares and own 42.27% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,074,108 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (7,462,543 shares), VANGUARD GROUP INC (4,189,024 shares), STATE STREET CORP (4,059,410 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2,122,005 shares), NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC (1,642,892 shares), MORGAN STANLEY (1,426,551 shares), MACQUARIE GROUP LTD (1,239,258 shares), Assenagon Asset Management S.A. (1,130,202 shares), and Nuveen Asset Management, LLC (1,023,965 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.